Biotech | March 06, 2026
FUJIFILM Biotechnologies launches purification technology for biologics
ShunzymeX leverages a proprietary protease to streamline purification
ShunzymeX leverages a proprietary protease to streamline purification
The facility is expected to become operational by FY2028-29
New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform
Liraglutide is a drug-device combination formulation used in the treatment of chronic weight management
One of India’s top integrated contract research, development, and manufacturing organizations (CRDMOs) is on a hiring spree
This multi-year CDMO agreement involves significant, ongoing manufacturing for a global pharmaceutical major
Expansion at the Oss (NL) site adds capacity and R&D capabilities, supporting the development and manufacturing of ADCs and other novel bioconjugates from First-in-Human to commercialization
Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal pigment epithelium (RPE) models
TED?A9 is part of S.Biomedics’ expanding pipeline of stem-cell-based therapies, developed using the company’s proprietary targeted embryonic stem cell differentiation platform
Operational leverage kicked in during the quarter, with adjusted EBITDA rising 21% year-on-year to Rs 147 crore
Subscribe To Our Newsletter & Stay Updated
